AI 摘要
我们查看了 amaryl 的 8 个实时结果,并筛选出最值得先比较的 3 个选项。
这份短名单里最突出的主题是 Combination Therapy 和 Prescription Medicine。
我们查看了 amaryl 的 8 个实时结果,并筛选出最值得先比较的 3 个选项。
这份短名单里最突出的主题是 Combination Therapy 和 Prescription Medicine。
来源: Sanofi
描述
Amaryl MV is a triple combination medication containing glimepiride, metformin, and voglibose. It is specifically formulated for patients with type 2 diabetes whose blood sugar is not adequately controlled by dual therapy. The addition of voglibose helps manage post-prandial (after-meal) blood glucose spikes.
适用场景
Intensive glycemic control, Post Prandial glucose management, Triple combination therapy 和 Advanced type 2 diabetes
评分
来源: Aventis Pharma
描述
Amaryl adalah merek orisinal untuk Glimepiride. Sebagai insulin secretagogue, obat ini merangsang sel-sel pankreas untuk memproduksi insulin guna menurunkan kadar glukosa darah.
适用场景
Stimulasi pankreas, Obat referensi, Diabetes tipe 2 和 Kontrol gula darah
评分
来源: Sanofi
描述
Amaryl M and Amaryl M Forte are fixed-dose combination therapies for type 2 diabetes. They combine glimepiride (1mg or 2mg) with metformin (500mg or 1000mg prolonged-release). These formulations are designed for patients who need the synergistic effect of two different antidiabetic mechanisms to achieve their target blood glucose levels.
适用场景
Dual Action diabetes therapy, Blood glucose management, Patients on metformin and glimepiride 和 Prolonged Release medication
评分
| 比较 | Amaryl MV | Amaryl | Amaryl M / Amaryl M Forte |
|---|---|---|---|
| 来源 | Sanofi | Aventis Pharma | Sanofi |
| 描述 | Amaryl MV is a triple combination medication containing glimepiride, metformin, and voglibose. It is specifically formulated for patients with type 2 diabetes whose blood sugar is not adequately controlled by dual therapy. The addition of voglibose helps manage post-prandial (after-meal) blood glucose spikes. | Amaryl adalah merek orisinal untuk Glimepiride. Sebagai insulin secretagogue, obat ini merangsang sel-sel pankreas untuk memproduksi insulin guna menurunkan kadar glukosa darah. | Amaryl M and Amaryl M Forte are fixed-dose combination therapies for type 2 diabetes. They combine glimepiride (1mg or 2mg) with metformin (500mg or 1000mg prolonged-release). These formulations are designed for patients who need the synergistic effect of two different antidiabetic mechanisms to achieve their target blood glucose levels. |
| 适用场景 | Intensive glycemic control, Post Prandial glucose management, Triple combination therapy 和 Advanced type 2 diabetes | Stimulasi pankreas, Obat referensi, Diabetes tipe 2 和 Kontrol gula darah | Dual Action diabetes therapy, Blood glucose management, Patients on metformin and glimepiride 和 Prolonged Release medication |
| 操作 | |||
| 评分 |
如果你想先看最均衡的选择,我推荐:
"Amaryl MV 来自 Sanofi."
我选择它是因为 This triple-action therapy provides a comprehensive approach to glycemic control, especially for managing post-meal blood sugar levels.